Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Chacruna Institute and Mexican grassroots organizations join forces in a Psilocybin Symposium to discuss the medicalization and commodification of psilocybin in the US

The International Symposium on Psilocybin: Therapeutic Potentials, Culture, and Decolonization, September 20-21, 2021 | A Two-Day Bilingual Virtual Conference Featuring Indigenous, Mexican, and Colombian Perspectives


News provided by

Chacruna Institute

Sep 13, 2021, 16:40 ET

Share this article

Share toX

Share this article

Share toX

International Psilocybin Symposium: Therapeutic potentials, culture and decolonization
International Psilocybin Symposium: Therapeutic potentials, culture and decolonization

MEXICO CITY, Sept. 13, 2021 /PRNewswire-PRWeb/ -- A host of scientific research and clinical trials around the world are affirming the remarkable effectiveness of psilocybin, the principal psychoactive component of "magic mushrooms," in the treatment of a variety of medical conditions, including depression, anxiety, addiction, and PTSD. These evidence-based health benefits are contributing to the destigmatization and celebration of psilocybin mushrooms and other psychedelics in the popular culture of the Global North. However, despite this burgeoning interest, the challenges brought about by psilocybin's growing globalization, commercialization, and medicalization is rarely addressed. Meanwhile, the realities of the Indigenous cultures that have long included sacred mushrooms in their ancestral healing practices remain almost entirely invisible.

In response to these challenges, the Chacruna Institute, along with the Mexican non-profit organizations Vía Synapsis, The Mexican Psilocybin Society, and MindSurf, have joined forces to hold The International Symposium on Psilocybin: Therapeutic Potentials, Culture, and Decolonization on September 20–21, 2021. This online event is the first of its kind to offer a platform for voices that are routinely left out of the so-called "Psychedelic Renaissance," providing decolonial perspectives on the ritual, therapeutic, scientific, cultural, and philosophical aspects of psilocybin and sacred mushrooms.

This symposium opens unique avenues of research to replace the hegemonic paradigms that prevail in the psychedelic renaissance with an approach based on reciprocity, justice, and solidarity.

Post this

This two-day, bilingual event includes prominent researchers, academics, Indigenous leaders, activists, and members of the psychedelic community, who will bring together different disciplines and local cultural knowledge to offer fresh perspectives on the most pressing issues in the global psychedelic movement, including debates few in the Global North are aware of.

"This symposium opens unique avenues of research to replace the hegemonic paradigms that prevail in the psychedelic renaissance with an approach based on reciprocity, justice, and solidarity. Join us in this event that provides a space where we can open our thoughts to a diversity of mental landscapes." -Osiris Sinuhé González Romero, Ph.D, Via Synapsis/ Chacruna Institute

"We need to go beyond the biomedical voices that dominate the public conversation about psychedelics. Only with philosophers, anthropologists, geographers, political scientists, historians, sociologists, activists, and community leaders will we make the psychedelic renaissance truly inclusive and equitable. We invite the leaders of the new psychedelic businesses and of decriminalization efforts in the US to come join this multicultural and bilingual conversation!" -Bia Labate, PhD, Chacruna's Institute Executive Director

The International Symposium on Psilocybin: Therapeutic Potentials, Culture, and Decolonization aims to address these issues head-on by recentering Indigenous voices and those from psychedelic communities in Mexico and Colombia. It will highlight ideas that interrogate and challenge those taken for granted in the Global North around psilocybin and sacred mushrooms in the hope of forging a more equitable and sustainable way forward for the psychedelic renaissance and to ensure public policies incorporate harm reduction, cognitive freedom, and Indigenous rights.

International Psilocybin Symposium: Therapeutic Potentials, Culture and Decolonization will take place on September 20th-21st 2021, 8:30 to 17:30 PST. To register for free, click here.

This event is proudly presented by Chacruna Institute, Via Synapsis, Sociedad Mexicana de Psilocibina, and Mindsurf.

About Chacruna Institute                                
The Chacruna Institute for Psychedelic Plant Medicines, an organization co-founded by Brazilian anthropologist Dr. Bia Labate and American psychologist Dr. Clancy Cavnar, produces high-quality research on plant medicines and psychedelics and helps propagate academic knowledge in more accessible formats. We educate the public and create cultural understanding and legitimacy regarding these substances so that they may cease to be stigmatized and outlawed. Chacruna also promotes a bridge between the world of plant medicines and the emergent field of psychedelic science, between "traditional ceremonial use" and clinical and therapeutic settings, bringing the knowledge and perspectives of the social sciences to health care professionals and practitioners of psychedelic-assisted therapy. Finally, we foster cultural and political reflections on the field of psychedelic science and facilitate conversations about controversial topics that have been simmering on the sidelines as psychedelics go mainstream.

Media Contact

Brystal Karber, Chacruna Institute, +1 415-390-6157, [email protected]

Twitter, Facebook

SOURCE Chacruna Institute

Related Links

http://www.chacruna.net/

Modal title

Codex Magliabechi, f.90 r. | A character consuming mushrooms is accompanied by Mictlantecuhtli, god of death. Painted during the XVI century, and refers to the Aztecs.⁠
Codex Magliabechi, f.90 r. | A character consuming mushrooms is accompanied by Mictlantecuhtli, god of death. Painted during the XVI century, and refers to the Aztecs.⁠
The topics of this timely symposium include: the history of uses of mushrooms; traditional Indigenous knowledge, healing, and spirituality; therapeutic potentials; conservation; decolonization; biopir
The topics of this timely symposium include: the history of uses of mushrooms; traditional Indigenous knowledge, healing, and spirituality; therapeutic potentials; conservation; decolonization; biopir
Codex Magliabechi, f.90 r. | A character consuming mushrooms is accompanied by Mictlantecuhtli, god of death. Painted during the XVI century, and refers to the Aztecs.⁠ The topics of this timely symposium include: the history of uses of mushrooms; traditional Indigenous knowledge, healing, and spirituality; therapeutic potentials; conservation; decolonization; biopir

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.